CUROGEN has been awarded a research grant from the Korea Drug Development Fund (KDDF) under the "Establishing R&D Ecosystem for Novel Drugs" category. The project will focus on early-stage drug candidates and is set to begin in October 2024, with a planned duration of two years. The grant totals 1.2 billion KRW.

With marks CUROGEN's fourth research grand from KDDF, further reinforcing our commitment to advancing innovative therapies in the field of drug development.